未登录

L

Lynn R. Webster

dr. vince clinical research

H指数:49

被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Postmarketing Research for Opioid Abuse-Deterrent Formulations: A Narrative Review

阿片类药物滥用阻制剂的上市后研究：一篇叙述性综述

Journal of Pain Research

IF2.5

2025-08-090

OA

Intranasal Human Abuse Potential of PF614: A Novel 'Next Generation' Trypsin Activated Abuse Protected (TAAP) Opioid

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2024-07-010

PRE

Establishing Minimal Clinically Important Differences in Quality of Life Measures in Opioid-Induced Constipation

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IF12

2022-04-016

OAAI

Evaluation of the abuse potential of difelikefalin, a selective kappa-opioid receptor agonist, in recreational polydrug users

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2021-10-2820

OAAI

HUMAN ABUSE POTENTIAL ASSESSMENT OF SERDEXMETHYLPHENIDATE (SDX), A NOVEL PRODRUG OF D-METHYLPHENIDATE

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

IF9.5

2020-10-010

PREAI

A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration on Respiratory Drive

ADVANCES IN THERAPY

IF4

2020-09-258

OAAI

Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age

IF3.8

2020-02-2113

OAAI

A Longitudinal Study of the Association of Opioid Use with Change in Pain Interference and Functional Limitations in a Nationally Representative Cohort of Adults with Osteoarthritis in the United States

ADVANCES IN THERAPY

IF4

2019-12-2417

OAAI

Clinical, humanistic, and economic burden of osteoarthritis among noninstitutionalized adults in the United States

OSTEOARTHRITIS AND CARTILAGE

IF9

2019-11-01109

OAAI

Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trials

JOURNAL OF PAIN

IF4

2019-10-017

OAAI

Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized Study

在一项随机研究中，羟考酮，羟考酮ARIR的滥用威慑，速释制剂的相对口服生物利用度

ADVANCES IN THERAPY

IF4

2019-05-071

OAAI

Desmetramadol has the Safety and Analgesic Profile of Tramadol but not its Metabolic Liabilities: Double-Blind, Randomized, Placebo-Controlled Trials in 103 Subjects

JOURNAL OF PAIN

IF4

2019-04-010

OAAI

Effects of intravenous oxycodone alone or in combination with naltrexone on measures of respiratory depression: a randomized placebo-controlled study

THERAPEUTIC ADVANCES IN DRUG SAFETY

IF3.4

2019-02-012

OAAI

The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. The Odyssey from Hope to Practice, Santorini, Greece, 30 September-3 October 2018

JOURNAL OF PERSONALIZED MEDICINE

IF3

2018-12-121

OAAI

DOSE-FINDING STUDY OF ABUSE-RELATED EFFECTS OF INTRANASAL D-METHYLPHENIDATE IN RECREATIONAL STIMULANT ABUSERS

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

IF9.5

2018-10-010

PREAI

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2018-07-243

OAAI

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2018-07-245

OAAI

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study

IF5.5

2018-02-0666

OAAI

Ventilator Hypercapnic Response (VHR) methodology

JOURNAL OF PAIN

IF4

2017-04-010

OAAI

Select characteristics of recreational of opioid users undergoing a human abuse potential study

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2017-02-010

PREAI